Impax Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Impax Laboratories ( IPXL) is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals. This stock is trading up 4.7% at $26.01 in recent trading.

Today's Volume: 816,000

Average Volume: 536,486

Volume % Change: 184%

>>5 Stocks With Big Insider Buying

From a technical perspective, IPXL is ripping higher here above-average volume, and its trending into breakout territory above some near-term overhead resistance levels at $25.31 to $25.36. At last check, IPXL has hit an intraday high of $26.08 and volume is well above its three-month average action of 536,486 shares.

Traders should now look for long-biased trades in IPXL as long as its trending above today's low of $24.75 with strong upside volume flows. I would consider any upside volume day that registers near or above 536,486 shares as bullish. If IPXL can hold that trend, and especially hold its trend above those breakout levels, then this stock has a great chance of re-testing or taking out its next major overhead resistance levels at $27 to $28.75 in the near future.

If you liked this article you might like

Eating McDonald's Stock Might Make You Sick

Investors in Restaurant Stocks Still Need Strong Stomachs

iPhone X, Bitcoin and Nordstrom - 5 Things You Must Know Before the Market Opens

Futures Hold Steady as Hurricane Irma Pummels Florida

Hurricane Irma Batters Florida and Fed Gets Inflation Numbers: Week Ahead